Prevalence of Rheumatic Heart Disease in Iran: A Systematic Review and Meta-analysis

Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 34

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JPRE-9-2_002

تاریخ نمایه سازی: 9 آذر 1402

Abstract:

Context: Rheumatic Heart Disease (RHD) remains the prominent cause of morbidity and mortality among young individuals in developing countries. The present research aimed to estimate the prevalence of RHD in Iran.  Data Sources: In this review, all population-based studies with a sample size of ≥۵۰۰ participants related to the prevalence of RHD were included. The search was conducted in national and international databases. The combination of medical subject headings and free-term text items concerning the incidence, prevalence, rheumatic fever, RHD, and Iran were used in this study.  Data Extraction: In this systematic review, ۴۹۰ papers were identified. A total of ۲۹۶ articles were screened; of which, ۹ qualified articles were selected for the final data analysis. All studies were of cross-sectional, and descriptive natures. Two authors used the data extraction form to independently extract relevant data from the included studies. Disagreements between the authors were reconciled through discussion and consensus. Results: The overall prevalence of RHD was calculated as ۰.۰۲% (۲۰/۱۰۰۰۰۰ population). This prevalence rate is estimated based on studies conducted in the northern, southern, eastern, western, and central regions of the country; therefore it could be an estimation of the relevant prevalence rate in Iran. However, there were no updated and high-quality data in this regard. Thus, the reported rate might be underestimated.  Conclusions: There is a need for a nationwide survey to investigate the precise prevalence of RHD in Iran. This can be achieved by creating a national database of RHD.

Authors

Zainab Qazizadeh

Department of Health Information Management, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.

Leila Shahmoradi

Halal Research Center of IRI, FDA, Tehran, Iran.

Mahmood Moosazadeh

Gastrointestinal Cancer Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.

Leila Shahbaznejad

Pediatric Infectious Diseases Research Center, Communicable Disease Institute, Mazandaran University of Medical Sciences, Sari, Iran.

Mohammad Sadegh Rezai

Pediatric Infectious Diseases Research Center, Communicable Disease Institute, Mazandaran University of Medical Sciences, Sari, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic ...
  • Remenyi B, Carapetis J, Wyber R, Taubert K, Mayosi BM. ...
  • Beaudoin A, Edison L, Introcaso CE, Goh L, Marrone J, ...
  • Parks T, Kado J, Miller AE, Ward B, Heenan R, ...
  • Katzenellenbogen JM, Ralph AP, Wyber R, Carapetis JR. Rheumatic heart ...
  • Karthikeyan G, Zühlke L, Engel M, Rangarajan S, Yusuf S, ...
  • Dam Jv, Musuku J, Zühlke LJ, Engel ME, Nestle N, ...
  • Dassel JLd, Ralpha AP, Carapetis JR. Controlling acute rheumatic fever ...
  • Woldu B, Bloomfield GS. Rheumatic Heart Disease in the Twenty-First ...
  • Zuhlke L, Engel ME, Karthikeyan G, Rangarajan S, PamMackie, Cupido ...
  • Tibazarwa KB, Volmink JA, Mayosi BM. Incidence of acute rheumatic ...
  • Abul-Fadl AMAM, Mourad MM, Ghamrawy A, Sarhan AE. Trends in ...
  • Rheumatic fever and rheumatic heart disease. World Health Organization; ۲۰۱۸ ...
  • Zuhlke L, Steer A. Estimates of the global burden of ...
  • Carapetis JR, Beaton A, Cunningham MW, Guilherme L, Karthikeyan G, ...
  • Carapetis J, Mayosi B, Kaplan E. Controlling rheumatic heart disease ...
  • Nkgudi B, Robertson K, Volmink J, Mayosi b. Notification of ...
  • Alqanatish J, Alfadhel A, Albelali A, Alqahtani D. Acute rheumatic ...
  • Montazeri M, Galeh TM, Moosazadeh M, Sarvi S, Dodangeh S, ...
  • Zühlke L, Watkins D, Engel ME. Incidence, prevalence and outcomes ...
  • Noubiap JJ, Agbor VN, Bigna JJ, Kaze AD, Nyaga UF, ...
  • Padmavati S. Rheumatic fever and rheumatic heart disease in developing ...
  • Jahanshahinasab A. Investigation of the prevalence of rheumatic cardiac valve ...
  • Niyabati Z. Prevalence of rheumatic heart disease in Tehran schools ...
  • Molavi A. Investigation of the prevalence of rheumatic heart disease ...
  • Haqiqi N. Investigation of the prevalence of rheumatic and congenital ...
  • Barzigar A, Akbar MH, Mirblook F, Shamkhani K, Zandi A, ...
  • Dadgar A. The evaluation of incidence rate of rheumatic heart ...
  • Zeinaloo A, AsadpoorPiranfar M. Prevalence of rheumatic heart disease during ...
  • Mahmoudi M, Rezaei N, Mahmoudi M. The prevalence of rheumatic ...
  • Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, ...
  • Action R. RHD Atlas [cited ۲۰۲۰ Jun ۱۰]. Available from: ...
  • Steer AC, Carapetis JR, Nolan TM, Shann F. Systematic review ...
  • Paar JA, Berrios NM, Rose JD, Cáceres M, Peña R, ...
  • Carapetis JR, Steer AC, Mulholland EK, Weber M. The global ...
  • Negi PC, Sondhi S, Asotra S, Mahajan K, Mehta A. ...
  • نمایش کامل مراجع